611 related articles for article (PubMed ID: 9809590)
41. Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites.
Ishiguro K; Sato K; Takamatsu M; Park J; Uchida T; Imahori K
Neurosci Lett; 1995 Dec; 202(1-2):81-4. PubMed ID: 8787836
[TBL] [Abstract][Full Text] [Related]
42. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
43. Combination of PKCε Activation and PTP1B Inhibition Effectively Suppresses Aβ-Induced GSK-3β Activation and Tau Phosphorylation.
Kanno T; Tsuchiya A; Tanaka A; Nishizaki T
Mol Neurobiol; 2016 Sep; 53(7):4787-97. PubMed ID: 26328540
[TBL] [Abstract][Full Text] [Related]
44. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
Forlenza OV; Spink JM; Dayanandan R; Anderton BH; Olesen OF; Lovestone S
J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110
[TBL] [Abstract][Full Text] [Related]
45. Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly.
Utton MA; Vandecandelaere A; Wagner U; Reynolds CH; Gibb GM; Miller CC; Bayley PM; Anderton BH
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):741-7. PubMed ID: 9169608
[TBL] [Abstract][Full Text] [Related]
46. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.
Lanzillotta A; Sarnico I; Benarese M; Branca C; Baiguera C; Hutter-Paier B; Windisch M; Spano P; Imbimbo BP; Pizzi M
J Mol Neurosci; 2011 Sep; 45(1):22-31. PubMed ID: 21181298
[TBL] [Abstract][Full Text] [Related]
47. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
48. Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases.
Williamson R; Scales T; Clark BR; Gibb G; Reynolds CH; Kellie S; Bird IN; Varndell IM; Sheppard PW; Everall I; Anderton BH
J Neurosci; 2002 Jan; 22(1):10-20. PubMed ID: 11756483
[TBL] [Abstract][Full Text] [Related]
49. Amyloid beta peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 beta in rat hippocampal neurons.
Takashima A; Yamaguchi H; Noguchi K; Michel G; Ishiguro K; Sato K; Hoshino T; Hoshi M; Imahori K
Neurosci Lett; 1995 Sep; 198(2):83-6. PubMed ID: 8592647
[TBL] [Abstract][Full Text] [Related]
50. Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta.
Takashima A; Noguchi K; Michel G; Mercken M; Hoshi M; Ishiguro K; Imahori K
Neurosci Lett; 1996 Jan; 203(1):33-6. PubMed ID: 8742040
[TBL] [Abstract][Full Text] [Related]
51. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
52. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.
Pei JJ; Braak E; Braak H; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
J Neuropathol Exp Neurol; 1999 Sep; 58(9):1010-9. PubMed ID: 10499443
[TBL] [Abstract][Full Text] [Related]
53. Sites of phosphorylation in tau and factors affecting their regulation.
Anderton BH; Betts J; Blackstock WP; Brion JP; Chapman S; Connell J; Dayanandan R; Gallo JM; Gibb G; Hanger DP; Hutton M; Kardalinou E; Leroy K; Lovestone S; Mack T; Reynolds CH; Van Slegtenhorst M
Biochem Soc Symp; 2001; (67):73-80. PubMed ID: 11447841
[TBL] [Abstract][Full Text] [Related]
54. Modulation of PHF-like tau phosphorylation in cultured neurones and transfected cells.
Anderton BH; Brion JP; Couck AM; Davis DR; Gallo JM; Hanger DP; Ladhani K; Latimer DA; Lewis C; Lovestone S
Neurobiol Aging; 1995; 16(3):389-97; discussion 398-402. PubMed ID: 7566348
[TBL] [Abstract][Full Text] [Related]
55. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Takashima A; Noguchi K; Sato K; Hoshino T; Imahori K
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7789-93. PubMed ID: 8356085
[TBL] [Abstract][Full Text] [Related]
56. Downregulation of glycogen synthase kinase-3beta (GSK-3beta) protein expression during neuroblastoma IMR-32 cell differentiation.
Muñoz-Montaño JR; Moreno FJ; Avila J; Díaz-Nido J
J Neurosci Res; 1999 Feb; 55(3):278-85. PubMed ID: 10348658
[TBL] [Abstract][Full Text] [Related]
57. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
[TBL] [Abstract][Full Text] [Related]
58. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
59. Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice.
Tomidokoro Y; Ishiguro K; Harigaya Y; Matsubara E; Ikeda M; Park JM; Yasutake K; Kawarabayashi T; Okamoto K; Shoji M
Neurosci Lett; 2001 Feb; 299(3):169-72. PubMed ID: 11165762
[TBL] [Abstract][Full Text] [Related]
60. Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments.
Ishiguro K; Omori A; Takamatsu M; Sato K; Arioka M; Uchida T; Imahori K
Neurosci Lett; 1992 Dec; 148(1-2):202-6. PubMed ID: 1284442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
